Atlas Trials

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

Clinical trial NCT00246194 · COMPLETED

Trial details

NCT number
NCT00246194
Sponsor
Janssen, LP
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2004-09-01
Primary completion
2007-11-01
Enrollment
532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.